Last reviewed · How we verify
NCT06295874
The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort
NA trial testing Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level in Respiratory Insufficiency in 61 participants. Status unknown.
30 August 2024
Quick facts
| Lead sponsor | Nilgün Erdoğan |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 61 |
| Start date | 5 January 2023 |
| Primary completion | 30 August 2024 |
| Estimated completion | 30 August 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level
Conditions studied
- Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
- Pulmonary Disease, Chronic Obstructive — all drugs for Pulmonary Disease, Chronic Obstructive →
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
- High Blood Pressure — all drugs for High Blood Pressure →
Sponsor
Nilgün Erdoğan
Who can join
18 and older, any sex, with Respiratory Insufficiency or Pulmonary Disease, Chronic Obstructive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients in the intensive care unit (ICU) experience physical and psychological discomfort, including pain. Anxiety is a condition frequently encountered in the ICU. The hospital environment, especially the ICU, is reported as a significant cause of anxiety for patients. Comfort is a holistic, subjective and multidimensional concept that is affected by physical, environmental, social and psycho-spiritual contexts and changes over time and space. Comfort in intensive care is often associated with pain relief and end-of-life care. Assessment tools have been developed to measure patient comfort in the ICU, including levels of pain, delirium, and sedation. This work; Patients who are monitored in intensive care under high-flow and oxygen are treated with a mixture of lavender, thyme and eucalyptus oil (20 ml; lavender oil 5 drops, thyme oil 4 drops, eucalyptus oil 3 drops and 20 ml almond oil) twice a day for three days. This study was conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on some physiological parameters, pain, anxiety and intensive care comfort of the patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06295874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Insufficiency
Currently open trials in the same condition.
- NCT06653166 — Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt i · active not recruiting
- NCT06483984 — Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout · NA · recruiting
- NCT05906030 — Diaphragm Dysfunction and Ultrasound Perioperatively · recruiting
- NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
- NCT06494215 — Comparison of Different Methods to Calculate Pendelluft by Electrical Impedance Tomography in Mechanically Ventilated Pa · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06295874 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nilgün Erdoğan
- Last refreshed: 6 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06295874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing